U.S. Department of Health and Human Services Awards Flu Vaccine Development Contract
The U.S. Department of Health and Human Services awarded a $35 million contract in June of 2009 to Protein Sciences Corporation of Meriden, Conn., to pursue advanced development of recombinant influenza vaccine. The technology involves injecting flu virus genes into an insect virus (baculovirus) where it multiplies quickly in the insect cells, which are purified to become a part of a human vaccine.